首頁 > 市場調查報告書 > 醫療設備

體外診斷生技設備

癌症的分子診斷市場:各癌症類型，各產品類型，場所預測 - 附執行指南(2024年～2028年)

市場調查報告書

商品編碼

1505238

癌症的分子診斷市場:各癌症類型，各產品類型，場所預測 - 附執行指南(2024年～2028年)

Molecular Diagnostics for Cancer. Markets Forecasts by Cancer Type, Product and Place with Executive and Consultant Guides and Customization. 2024 to 2028

出版日期: 2024年06月12日 | 出版商:

Howe Sound Research | 英文 442 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

分子癌症診斷再次走上成長軌道。每個細分市場的成長都在加速。

令人興奮的技術發展，特別是在伴隨診斷方面，預示著一個充滿活力、不斷增長和不斷發展的全球市場，在這個市場中，單一實驗室可以為全球患者群提供服務。

本報告提供全球癌症的按分子診斷市場相關調查，提供市場概要，以及各癌症類型，各產品類型，場所趨勢，及加入此市場的主要企業簡介等資訊。

10x Genomics, Inc.
Abbott Laboratories
AccuraGen Inc.
Acuamark Diagnostics
Adaptive Biotechnologies
Admera Health, LLC
Aethlon Medical
Agilent
Amoy Diagnostics Co., Ltd.
Anchor Dx
ANGLE plc
ARUP Laboratories
AVIVA Systems Biology
Baylor Miraca Genetics Laboratories
Beckman Coulter Diagnostics(Danaher)
Becton, Dickinson and Company
BGI Genomics Co. Ltd
BillionToOne
Bioarray Genetics
Biocartis
Biocept, Inc.
Biodesix Inc.
BioFluidica
BioGenex
BioIVT
Biolidics Ltd
bioMerieux Diagnostics
Bioneer Corporation
Bio-Rad Laboratories, Inc
Bio-Reference Laboratories
Bio-Techne
Bioview
Bristol-Myers Squibb
Burning Rock
C2i Genomics
Cardiff Oncology
Caris Molecular Diagnostics
Castle Biosciences, Inc.
Celemics
CellCarta
CellMax Life
Cepheid(Danaher)
Charles River Laboratories
Circulogene
Cizzle Biotech
Clearbridge Biomedics
Clinical Genomics
Cytolumina Technologies Corp.
Datar Cancer Genetics Limited
Diagnologix LLC
Diasorin S.p.A.
Dxcover
Element Biosciences
Enzo Biochem
Epic Sciences
Epigenomics AG
Erythra
Eurofins Scientific
Exact Sciences
Fabric Genomics
Fluxion Biosciences(Cell Microsystems)
Freenome
FUJIFILM Wako Diagnostics
Fujirebio
Fulgent Genetics
Fyr Diagnostics
GeneDx Holdings
GeneFirst Ltd.
Genetron Holdings
GenomOncology
GILUPI Nanomedizin
Guardant Health
HansaBiomed
HTG Molecular Diagnostics
iCellate
ICON PLC
Illumina
Incell Dx
Inivata
INOVIQ
Invitae Corporation
Invivogen
Invivoscribe
J&J Innovative Medicine
Lucence Health
Lunglife AI Inc
MDNA Life SCIENCES, Inc.
MDx Health
Menarini Silicon Biosystems
Mesa Laboratories, Inc.
Metabiomics Corp
Millipore Sigma
Miltenyi Biotec
miR Scientific
Myriad Genetics
Nanostring
NantHealth, Inc.
Natera
NeoGenomics
NGeneBio
Novogene
Oncimmune
Oncocyte
OncoDNA
Oncohost
OraLiva
Oxford Nanopore Technologies
PamGene
Panagene
Personalis
Perthera
PGDx(Labcorp)
Precipio
PrecisionMed
Predicine
Predictive Oncology
Prenetics
Promega
Qiagen
QuidelOrtho
Rarecells SAS
RareCyte
Revvity
Roche Diagnostics
Screencell
Sherlock Biosciences
Siemens Healthineers
simfo GmbH
Singlera Genomics Inc.
Singular Genomics
Singulomics
SkylineDx
Standard BioTools
Stilla Technologies
Sysmex Inostics
Tempus Labs, Inc.
Thermo Fisher Scientific
Todos Medical
Ultima Genomics
Variantyx
Vela Diagnostics
Veracyte
VolitionRX
Vortex Biosciences
Zhejiang Orient Gene Biotech

第7章 MDx癌症的全球市場

全球市場概要，各國
全球市場- 概要，各癌症類型
全球市場- 概要，各產品類型
全球市場- 概要，各地區

第8章全球市場，各癌症類型

乳癌
大腸癌症
子宮頸癌症
肺癌症
前列腺癌症
黑色素瘤
血液癌症
伴隨式診斷開發
其他

第9章全球市場，各產品類型

設備
試劑
軟體及服務

第10章按全球市場，場所

臨床檢驗室
製藥
研究

第11章癌症治療和臨床試驗

第12章附錄

簡介目錄圖表

OVERVIEW:

Cancer Molecular Diagnostics is back on the growth path. And growth is accelerating in every segment. We include a special segment Cancer Companion Diagnostics, a new segment of the market that is reshaping the industry. Over 140 companies are profiled. A range of dynamic trends are pushing market growth and company valuations.

Trends like:

personalized medicine
pharmacogenomics
liquid biopsy
minimal residual disease testing
emergence of new economies with large markets
physician diagnostics being displaced by new intelligent diagnostic tests

Exciting technical developments especially in companion diagnostics, hold the promise of a dynamic, growing and evolving world market where single laboratories serve a global patient base.

The report includes detailed breakouts for 18 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

B.Sc. (Chemistry) University of BC
M.B.A. (Finance and Policy) University of BC
Market Research Seminar - Burke Institute
Finance for Senior Executives - Harvard Business School

1 Market Guides

1.1 Cancer MDx - Strategic Situation Analysis
1.2 Guide for Executives, Marketing, and Business Development Staff
1.3 Guide for Management Consultants and Investment Advisors

2 Introduction and Market Definition

2.1 What are Molecular Diagnostics?
2.2 The Diagnostics Revolution
2.3 Market Definition
- 2.3.1 Revenue Market Size
2.4 Methodology
- 2.4.1 Methodology
- 2.4.2 Sources
- 2.4.3 Authors
2.5 Perspective: Healthcare and the IVD Industry
- 2.5.1 Global Healthcare Spending
- 2.5.2 Spending on Diagnostics
- 2.5.3 Important Role of Insurance for Diagnostics

3 Market Overview

3.1 Market Segments
- 3.1.1 Traditional Market Segmentation
- 3.1.2 Laboratory Focus and Segmentation
3.2 Industry Structure
- 3.2.1 Hospital Testing Share
- 3.2.2 Economies of Scale
- 3.2.3 Physician Office Lab's
- 3.2.4 Physician's and POCT

4 Market Trends

4.1 Factors Driving Growth
- 4.1.1 New Diagnostics Create New Markets
- 4.1.2 New Roles for Diagnostics
- 4.1.3 Aging Effect
- 4.1.4 Expanding the Pharmaceutical Toolbox
- 4.1.5 Regulatory Retreat
4.2 Factors Limiting Growth
- 4.2.1 Falling Prices
- 4.2.2 Lower Costs
- 4.2.3 Wellness has a Downside
4.3 Instrumentation, Automation and Diagnostic Trends
- 4.3.1 Traditional Automation and Centralization
- 4.3.2 The New Automation, Decentralization and Point Of Care
- 4.3.3 Instruments Key to Market Share
- 4.3.4 Bioinformatics Plays a Role
- 4.3.5 PCR Takes Command
- 4.3.6 Next Generation Sequencing Fuels a Revolution
- 4.3.7 NGS Impact on Pricing
- 4.3.8 Whole Genome Sequencing, A Brave New World
- 4.3.9 Companion Diagnostics Blurs Diagnosis and Treatment
- 4.3.10 Shifting Role of Diagnostics
- 4.3.11 Multiplexing and Foundation One
- 4.3.12 Pharmacogenomics Technology
- 4.3.13 Gene Editing and Gene Therapy

5 Molecular Diagnostics Recent Developments

5.1 Recent Developments - Importance and How to Use This Section
- 5.1.1 Importance of These Developments
- 5.1.2 How to Use This Section
5.2 Foundation Medicine, Repare Therapeutics to Develop CDx
5.3 NHS Declines to Accelerate Grail Galleri Implementation
5.4 GeneDx Sees Growing Demand for Testing
5.5 Thermo Fisher and Bayer to Develop CDx for Cancer Therapies
5.6 ClearNote Health Expands Into Immunotherapy Monitoring
5.7 Foundation Medicine to Collaborate on CDx for Lung Cancer
5.8 Qiagen and Myriad Genetics Partner to Develop Cancer CDx
5.9 Lung Cancer Data Heralds Shift for Hummingbird Dx
5.10 PamGene Awarded Euro-7.5M for Immunotherapy Test
5.11 Grail Cancer Test Faces New Clinical Questions
5.12 Freenome Acquires Cancer Dx Firm Oncimmune
5.13 Quest Diagnostics to Acquire Liquid Biopsy Firm Haystack Oncology
5.14 Ultima Genomics, Genome Insight Partner on WGS for Cancer Patients
5.15 Digital Pathology Meets Cancer Sequencing
5.16 Exact Sciences Preps Expanded Oncology Portfolio
5.17 Qiagen Details Oncology Plans for Digital PCR Platform
5.18 Sema4 Exiting Reproductive Health Screening
5.19 Thermo Fisher Introduces Cancer Profiling Assay
5.20 Genomic Test IDs Cysts Likely to Progress to Cancer
5.21 Naveris to Commercialize Virus-Related Cancer Tests
5.22 Larger Liquid Biopsy Panels Loom
5.23 Halo Diagnostics to Offer Genomic Profiling Tests
5.24 BillionToOne Raises $125M
5.25 Local Cancer Genomic Profiling Options Grow
5.26 German MDx Firm Mainz Biomed Raises $10M in IPO
5.27 Guardant Health Q3 Revenues Up 27 Percent
5.28 BforCure Raises $2.3M to Adapt Rapid PCR Platform for Cancer Detection
5.29 Nucleix to Invest in Early-Stage Lung Cancer Dx
5.30 Labcorp, GeneCentric Partnering on Development of RNA-Based Cancer Diagnostics
5.31 Grail Gets Approval for Galleri Multicancer Test
5.32 Finnish Firms to Form Point-of-Care Testing Firm
5.33 Datar Cancer Genetics Expands to Dx and Screening
5.34 HTG Molecular Diagnostics: HTG Transcriptome Panel
5.35 PacBio's Omniome Acquisition Shortens Path to Clinical
5.36 Invitae to Acquire Genosity for $200M
5.37 Bio-Techne Obtains CE Mark for Exosomal Liquid Biopsy Prostate Test
5.38 Agilent Technologies to Acquire Liquid Biopsy Firm Resolution Bioscience
5.39 Natera Revenues Grow 35 Percent
5.40 AnchorDx Closes $40M Financing Round
5.41 Exact Sciences Strategy for End-to-End Cancer Testing
5.42 Genomics England: Whole Genome Sequencing for Cancer Patients to Launch

6 Profiles of Key MDx Companies

6.1 10x Genomics, Inc.
6.2 Abbott Laboratories
6.3 AccuraGen Inc.
6.4 Acuamark Diagnostics
6.5 Adaptive Biotechnologies
6.6 Admera Health, LLC
6.7 Aethlon Medical
6.8 Agilent
6.9 Amoy Diagnostics Co., Ltd.
6.10 Anchor Dx
6.11 ANGLE plc
6.12 ARUP Laboratories
6.13 AVIVA Systems Biology
6.14 Baylor Miraca Genetics Laboratories
6.15 Beckman Coulter Diagnostics (Danaher)
6.16 Becton, Dickinson and Company
6.17 BGI Genomics Co. Ltd
6.18 BillionToOne
6.19 Bioarray Genetics
6.20 Biocartis
6.21 Biocept, Inc.
6.22 Biodesix Inc.
6.23 BioFluidica
6.24 BioGenex
6.25 BioIVT
6.26 Biolidics Ltd
6.27 bioMerieux Diagnostics
6.28 Bioneer Corporation
6.29 Bio-Rad Laboratories, Inc
6.30 Bio-Reference Laboratories
6.31 Bio-Techne
6.32 Bioview
6.33 Bristol-Myers Squibb
6.34 Burning Rock
6.35 C2i Genomics
6.36 Cardiff Oncology
6.37 Caris Molecular Diagnostics
6.38 Castle Biosciences, Inc.
6.39 Celemics
6.40 CellCarta
6.41 CellMax Life
6.42 Cepheid (Danaher)
6.43 Charles River Laboratories
6.44 Circulogene
6.45 Cizzle Biotech
6.46 Clearbridge Biomedics
6.47 Clinical Genomics
6.48 Cytolumina Technologies Corp.
6.49 Datar Cancer Genetics Limited
6.50 Diagnologix LLC
6.51 Diasorin S.p.A.
6.52 Dxcover
6.53 Element Biosciences
6.54 Enzo Biochem
6.55 Epic Sciences
6.56 Epigenomics AG
6.57 Erythra
6.58 Eurofins Scientific
6.59 Exact Sciences
6.60 Fabric Genomics
6.61 Fluxion Biosciences (Cell Microsystems)
6.62 Freenome
6.63 FUJIFILM Wako Diagnostics
6.64 Fujirebio
6.65 Fulgent Genetics
6.66 Fyr Diagnostics
6.67 GeneDx Holdings
6.68 GeneFirst Ltd.
6.69 Genetron Holdings
6.70 GenomOncology
6.71 GILUPI Nanomedizin
6.72 Guardant Health
6.73 HansaBiomed
6.74 HTG Molecular Diagnostics
6.75 iCellate
6.76 ICON PLC
6.77 Illumina
6.78 Incell Dx
6.79 Inivata
6.80 INOVIQ
6.81 Invitae Corporation
6.82 Invivogen
6.83 Invivoscribe
6.84 J&J Innovative Medicine
6.85 Lucence Health
6.86 Lunglife AI Inc
6.87 MDNA Life SCIENCES, Inc.
6.88 MDx Health
6.89 Menarini Silicon Biosystems
6.90 Mesa Laboratories, Inc.
6.91 Metabiomics Corp
6.92 Millipore Sigma
6.93 Miltenyi Biotec
6.94 miR Scientific
6.95 Myriad Genetics
6.96 Nanostring
6.97 NantHealth, Inc.
6.98 Natera
6.99 NeoGenomics
6.100 NGeneBio
6.101 Novogene
6.102 Oncimmune
6.103 Oncocyte
6.104 OncoDNA
6.105 Oncohost
6.106 OraLiva
6.107 Oxford Nanopore Technologies
6.108 PamGene
6.109 Panagene
6.110 Personalis
6.111 Perthera
6.112 PGDx (Labcorp)
6.113 Precipio
6.114 PrecisionMed
6.115 Predicine
6.116 Predictive Oncology
6.117 Prenetics
6.118 Promega
6.119 Qiagen
6.120 QuidelOrtho
6.121 Rarecells SAS
6.122 RareCyte
6.123 Revvity
6.124 Roche Diagnostics
6.125 Screencell
6.126 Sherlock Biosciences
6.127 Siemens Healthineers
6.128 simfo GmbH
6.129 Singlera Genomics Inc.
6.130 Singular Genomics
6.131 Singulomics
6.132 SkylineDx
6.133 Standard BioTools
6.134 Stilla Technologies
6.135 Sysmex Inostics
6.136 Tempus Labs, Inc.
6.137 Thermo Fisher Scientific
6.138 Todos Medical
6.139 Ultima Genomics
6.140 Variantyx
6.141 Vela Diagnostics
6.142 Veracyte
6.143 VolitionRX
6.144 Vortex Biosciences
6.145 Zhejiang Orient Gene Biotech

7 The Global Market for MDx Cancer

7.1 MDx Cancer - Global Market Overview by Country
- 7.1.1 Table - Global Market by Country
- 7.1.2 Chart - Global Market by Country
7.2 Global Market by Cancer Type - Overview
- 7.2.1 Table - Global Market by Cancer Type
- 7.2.2 Chart - Global Market by Cancer Type - Base/Final Comparison
- 7.2.3 Chart - Global Market by Cancer Type - Base Year
- 7.2.4 Chart - Global Market by Cancer Type -Final Year
- 7.2.5 Chart - Global Market by Cancer Type - Share by Year
- 7.2.6 Chart - Global Market by Cancer Type - Segment Growth
7.3 Global Market by Product Type - Overview
- 7.3.1 Table - Global Market by Product Type
- 7.3.2 Chart - Global Market by Product Type - Base/Final Comparison
- 7.3.3 Chart - Global Market by Product Type - Base Year
- 7.3.4 Chart - Global Market by Product Type -Final Year
- 7.3.5 Chart - Global Market by Product Type - Share by Year
- 7.3.6 Chart - Global Market by Product Type - Segment Growth
7.4 Global Market by Place - Overview
- 7.4.1 Table - Global Market by Place
- 7.4.2 Chart - Global Market by Place - Base/Final Comparison
- 7.4.3 Chart - Global Market by Place - Base Year
- 7.4.4 Chart - Global Market by Place -Final Year
- 7.4.5 Chart - Global Market by Place - Share by Year
- 7.4.6 Chart - Global Market by Place - Segment Growth

8 Global Market by Cancer Type

8.1 MDx Breast Cancer
- 8.1.1 Table Breast Cancer Testing - by Country
- 8.1.2 Chart - Breast Cancer Testing Growth
8.2 MDx Colorectal Cancer
- 8.2.1 Table Colorectal Cancer Testing - by Country
- 8.2.2 Chart - Colorectal Cancer Testing Growth
8.3 MDx Cervical Cancer
- 8.3.1 Table Cervical Cancer Testing - by Country
- 8.3.2 Chart - Cervical Cancer Testing Growth
8.4 MDx Lung Cancer
- 8.4.1 Table Lung Cancer Testing - by Country
- 8.4.2 Chart - Lung Cancer Testing Growth
8.5 MDx Prostate
- 8.5.1 Table Prostate Testing - by Country
- 8.5.2 Chart - Prostate Testing Growth
8.6 MDx Melanoma Cancer
- 8.6.1 Table Melanoma Cancer Testing - by Country
- 8.6.2 Chart - Melanoma Cancer Testing Growth
8.7 MDx Blood
- 8.7.1 Table Blood Testing - by Country
- 8.7.2 Chart - Blood Testing Growth
8.8 MDx Companion Dx Development
- 8.8.1 Table Companion Dx Development - by Country
- 8.8.2 Chart - Companion Dx Development Growth
8.9 MDx Other Cancer
- 8.9.1 Table Other Cancer Testing - by Country
- 8.9.2 Chart - Other Cancer Testing Growth

9 Global Market by Product Type

9.1 MDx Instruments
- 9.1.1 Table Instruments - by Country
- 9.1.2 Chart - Instruments Growth
9.2 MDx Reagents
- 9.2.1 Table Reagents - by Country
- 9.2.2 Chart - Reagents Growth
9.3 MDx Software and Services
- 9.3.1 Table Software and Services - by Country
- 9.3.2 Chart - Software and Services Growth

10 Global Market by Place

10.1 MDx Clinical Laboratory
- 10.1.1 Table Clinical Laboratory - by Country
- 10.1.2 Chart - Clinical Laboratory Growth
10.2 MDx Pharmaceutical
- 10.2.1 Table Pharmaceutical - by Country
- 10.2.2 Chart - Pharmaceutical Growth
10.3 MDx Research
- 10.3.1 Table Research - by Country
- 10.3.2 Chart - Research Growth